Literature DB >> 15478152

Longitudinal comparison of the Health Assessment Questionnaire (HAQ) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC).

Bonnie Bruce1, James Fries.   

Abstract

OBJECTIVE: To compare the measurement properties of the generic Health Assessment Questionnaire (HAQ) and the disease-specific Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC).
METHODS: Physical function, pain, and radiographic progression were assessed in knee or hip osteoarthritis patients (n = 271) who had 2 radiographs that were at least 6 months apart from 6 ARAMIS (Arthritis, Rheumatism, and Aging Medical Information System) databanks. Data were compared at baseline and after a mean of 3.2 (SE 0.10) years. Correlation coefficients and standardized effect sizes (SES) were used to assess their relationship and responsiveness.
RESULTS: The majority of items in the 2 function and pain scales overlapped and were highly and significantly correlated with each other at baseline and last assessments (function at baseline rs = 0.71 and function at last assessment rs = 0.79, P < 0.0001; pain at baseline rs = 0.70 and pain at last assessment rs = 0.76, P < 0.0001). The HAQ disability index and total knee score were more sensitive to detection of disease progression than the WOMAC (SES for HAQ = 0.27; SES for WOMAC = -0.05).
CONCLUSION: Both instruments showed favorable measurement properties, with the HAQ having the advantages of being more sensitive to change and adaptable to a wide variety of diseases and conditions, which contribute to the generalizability of findings.

Entities:  

Mesh:

Year:  2004        PMID: 15478152     DOI: 10.1002/art.20695

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  8 in total

1.  Localized hyperthermia induced by microwave diathermy in osteoarthritis of the knee: a randomized placebo-controlled double-blind clinical trial.

Authors:  Arrigo Giombini; Annalisa Di Cesare; Mariachiara Di Cesare; Maurizio Ripani; Nicola Maffulli
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-12-15       Impact factor: 4.342

2.  Reduced disability and mortality among aging runners: a 21-year longitudinal study.

Authors:  Eliza F Chakravarty; Helen B Hubert; Vijaya B Lingala; James F Fries
Journal:  Arch Intern Med       Date:  2008-08-11

3.  Lifestyle risk factors predict disability and death in healthy aging adults.

Authors:  Eliza F Chakravarty; Helen B Hubert; Eswar Krishnan; Bonnie B Bruce; Vijaya B Lingala; James F Fries
Journal:  Am J Med       Date:  2012-02       Impact factor: 4.965

4.  Evaluation and prediction of health-related quality of life for total hip replacement among Chinese in Taiwan.

Authors:  Hon-Yi Shi; Herng-Chia Chiu; Je-Ken Chang; Jun-Wen Wang; Richard Culbertson; M Mahmud Khan
Journal:  Int Orthop       Date:  2006-10-24       Impact factor: 3.075

5.  Non-pharmacological care for patients with generalized osteoarthritis: design of a randomized clinical trial.

Authors:  Thomas J Hoogeboom; Mirelle J P M Stukstette; Rob A de Bie; Jessica Cornelissen; Alfons A den Broeder; Cornelia H M van den Ende
Journal:  BMC Musculoskelet Disord       Date:  2010-07-01       Impact factor: 2.362

Review 6.  Patient-Reported Measures of Physical Function in Knee Osteoarthritis.

Authors:  Daniel K White; Hiral Master
Journal:  Rheum Dis Clin North Am       Date:  2016-03-17       Impact factor: 2.670

7.  The association of disability and pain with individual and community socioeconomic status in people with hip osteoarthritis.

Authors:  Joshua B Knight; Leigh F Callahan; My-Linh N Luong; Jack Shreffler; Britta Schoster; Jordan B Renner; Joanne M Jordan
Journal:  Open Rheumatol J       Date:  2011-10-18

8.  Comparison of patient- and clinician-reported outcome measures in lower back rehabilitation: introducing a new integrated performance measure (t2D).

Authors:  Andrej Zdravkovic; Vincent Grote; Michael Pirchl; Martin Stockinger; Richard Crevenna; Michael J Fischer
Journal:  Qual Life Res       Date:  2021-06-15       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.